News | August 02, 2021
Glenmark signs agreement with SaNOtize to manufacture NONS
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
TROPION-Lung01, evaluating AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan versus chemotherapy, previously met the dual primary endpoint of progression-free survival in the overall trial population
The approved ANDA is therapeutically equivalent to the reference listed drug product
Application based on results from the TROPION-Breast01 Phase III trial
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The validations confirm the completion of the applications and commence the scientific review process
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
Subscribe To Our Newsletter & Stay Updated
